Early and exclusive enteral nutrition in infants born very preterm.

Growth Intensive Care Units, Neonatal Neonatology

Journal

Archives of disease in childhood. Fetal and neonatal edition
ISSN: 1468-2052
Titre abrégé: Arch Dis Child Fetal Neonatal Ed
Pays: England
ID NLM: 9501297

Informations de publication

Date de publication:
22 Dec 2023
Historique:
received: 15 06 2023
accepted: 15 12 2023
medline: 23 12 2023
pubmed: 23 12 2023
entrez: 22 12 2023
Statut: aheadofprint

Résumé

To characterise the effects of early and exclusive enteral nutrition with either maternal or donor milk in infants born very preterm (28 Parallel-group, unmasked randomised controlled trial. Regional, tertiary neonatal intensive care unit. 102 infants born very preterm between 2021 and 2022 (51 in each group). Infants randomised to the intervention group received 60-80 mL/kg/day within the first 36 hours after birth. Infants randomised to the control group received 20-30 mL/kg/day (standard trophic feeding volumes). The primary outcome was the number of full enteral feeding days (>150 mL/kg/day) in the first 28 days after birth. Secondary outcomes included growth and body composition at the end of the first two postnatal weeks, and length of hospitalisation. The mean birth weight was 1477 g (SD: 334). Half of the infants were male, and 44% were black. Early and exclusive enteral nutrition increased the number of full enteral feeding days (+2; 0-2 days; p=0.004), the fat-free mass-for-age z-scores at postnatal day 14 (+0.5; 0.1-1.0; p=0.02) and the length-for-age z-scores at the time of hospital discharge (+0.6; 0.2-1.0; p=0.002). Hospitalisation costs differed between groups (mean difference favouring the intervention group: -$28 754; -$647 to -$56 861; p=0.04). In infants born very preterm, early and exclusive enteral nutrition increases the number of full enteral feeding days. This feeding practice may also improve fat-free mass accretion, increase length and reduce hospitalisation costs. NCT04337710.

Identifiants

pubmed: 38135494
pii: archdischild-2023-325969
doi: 10.1136/archdischild-2023-325969
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT04337710']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: AAS has a patent for an instrumented feeding bottle. Additionally, AAS has provided scientific advice to Resbiotic, received consulting fees for participating in advisory board meetings for Reckitt/Mead Johnson Nutrition and received speaking fees for participating in educational activities organised by p-value communications and WebMD.

Auteurs

Jacqueline Razzaghy (J)

Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

Vivek V Shukla (VV)

Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

Emily Gunawan (E)

Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

Audrey Reeves (A)

Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

Kelly Nguyen (K)

Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

Ariel A Salas (AA)

Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, Alabama, USA asalas@peds.uab.edu.

Classifications MeSH